ABCA1 and chronic kidney disease: Ganda et al. [51] did not find any alteration in cholesterol efflux mediated by apoB-depleted serum isolated from subjects with CKD (stages 4 and 5), although the expression of ABCA1 in monocytes isolated from those subjects was reduced, compromising cholesterol efflux to apoA-I.